Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 20 and 70 years old.
- Women who have been diagnosed with a primary invasive breast cancer through a biopsy.
- Women where the cancer is suspected to have spread to the lymph nodes in the armpit, and this has been confirmed through a needle sample or biopsy.
- People whose cancer has been clinically staged as T1 to T4, N1 to N3 (confirm with trial site for what this means in individual cases).
- People who have been fully informed about the trial and have signed a consent form agreeing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who did not have adequate imaging of the armpit area before surgery.
- People whose breast cancer has come back (recurrent), or who have inflammatory breast cancer.
- People whose breast cancer has spread to other parts of the body (Stage 4).
- People who have had an allergic reaction to any ingredients in the study drug being used in this trial.
- People who are scheduled for a type of armpit surgery that does not involve targeting the specific area this trial focuses on (confirm with trial site).
- People who have an active connective tissue disease, such as scleroderma or lupus, that has affected the skin.
- People with locally advanced or inflammatory locally advanced breast cancer that cannot be treated with surgery.
- People who have had an allergic reaction to the main ingredient or any other components of the study drug.
- Women who could become pregnant during the trial and do not agree to use a highly effective, non-hormonal contraceptive method (such as sterilisation, an intrauterine device, complete abstinence, or a partner who has had a vasectomy) from the time of the study drug injection through to the follow-up visit.
- Women who are currently pregnant or breastfeeding.
- People who have taken part in another clinical trial within 12 weeks before joining this trial.
- People whom the trial doctor considers unsuitable for participation for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Korean Breast Cancer Society Study Group, Korean Breast Cancer Society Study Group
Phone: 82-53-200-2707
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Accuracy of the axillary lymph node targeting method; Comparison the accuracy rate between LuminoMark group and conventional group
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.